Aparna Goel Nair, M.D. – FDA Inspection, Apr 19, 2024

Record Details

This FDA Inspection record concerns Aparna Goel Nair, M.D., with an inspection on April 19, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Aparna Goel Nair, M.D.
Inspection Date: April 19, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Cynthia J. Tsui (Investigator)
Linh Tu

View Company Profile

ID · accca249-5c13-4fdf-9bd7-3a72a5d2940d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1236395
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.62(b)Case history records- inadequate or inadequate
21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aparna Goel Nair, M.D.

FDA Inspection

Aparna Goel Nair, M.D.April 19, 2024